Statera Biopharma, Inc. Annual Return On Equity in % from 2012 to 2021

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Statera Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2021.
  • Statera Biopharma, Inc. Return On Equity for the quarter ending September 30, 2022 was 1.75K %.
  • Statera Biopharma, Inc. annual Return On Equity for 2021 was -111 %, a 576% decline from 2020.
  • Statera Biopharma, Inc. annual Return On Equity for 2020 was -16.4 %, a 98.5% increase from 2019.
  • Statera Biopharma, Inc. annual Return On Equity for 2019 was -1.13K %, a 1394% decline from 2018.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2021 -111 -94.3 -576% Jan 1, 2021 Dec 31, 2021
2020 -16.4 +1.11K +98.5% Jan 1, 2020 Dec 31, 2020
2019 -1.13K -1.05K -1394% Jan 1, 2019 Dec 31, 2019
2018 -75.3 Jan 1, 2018 Dec 31, 2018
2013 -343 -224 -189% Jan 1, 2013 Dec 31, 2013
2012 -119 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.